Showing results (661-670 of 902) with videos related to
Sort By:
Pageof 91
JNCI Cancer Spectrum|June 2, 2025
INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curseYu Yang Soon, Katrin Sjoquist, Ian C Marschner, et al.Journal of Medicinal Chemistry|September 11, 2024
Tuning RXR Modulators for PGC1α RecruitmentFelix Nawa, Minh Sai, Jan Vietor, et al.Hematological Oncology|May 9, 2020
Rare lymphomas in routine practice-Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic NeoplasmsWolfgang Knauf, Wolfgang Abenhardt, Hans Rainer Slawik, et al.ACS Applied Materials & Interfaces|November 22, 2021
Photoinduced Delamination of Metal-Organic Framework Thin Films by Spatioselective Generation of Reactive Oxygen SpeciesXiaojing Liu, Antoine Mazel, Stefan Marschner, et al.Hospital Pediatrics|September 14, 2022
Nephrotoxic Exposures and Acute Kidney Injury in Noncritically Ill Children Stratified by ServicePage E Holsteen, Katja M Gist, John T Brinton, et al.Frontiers in Immunology|October 16, 2018
The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney DiseaseJulian A Marschner, Shrikant R Mulay, Stefanie Steiger, et al.Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 9, 2019
Red Blood Cells Derived from Whole Blood Treated with Riboflavin and UV Light Maintain Adequate Cell Quality through 21 Days of StorageLina Y Dimberg, Suzann K Doane, Susan Yonemura, et al.The Journal of Infectious Diseases|February 1, 1995
Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in IndonesiaT A Ruff, D M Gertig, B F Otto, et al.International Journal for Parasitology. Parasites and Wildlife|April 14, 2025
Pharmacokinetics and safety of topical fluralaner in koalas (Phascolarctos cinereus )Ellyssia T Young, Jessica McKelson, Daniel Kalstrom, et al.Breast Care (Basel, Switzerland)|April 10, 2014
HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast CancerNadia Harbeck, Matthias W Beckmann, Achim Rody, et al.Pageof 91